Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates
Product sales and commercial rights revenues in 2025 increased 90% year-over-year to…
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated…
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position…
InspireSemi Provides Administrative Updates
VANCOUVER, British Columbia and AUSTIN, Texas, Jan. 16, 2026 (GLOBE NEWSWIRE) --…
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026 10:30 ET | Source: BridgeBio Pharma, Inc. - Preliminary unaudited…
Visionary Holdings Inc. Announces Key Governance Updates, Strategic Pivot to High-End Medical Aesthetics, and Timeline for Annual Report Filing
MARKHAM, Ontario, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (the…
Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Xojo 2025r3 Delivers Major Updates, New Libraries Feature, Integrated AI Assistant, and Modern OS Support
AUSTIN, Texas, Dec. 16, 2025 /PRNewswire/ -- Xojo, Inc., the developers behind…
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
November 02, 2025 19:00 ET | Source: HUTCHMED (China) Limited — HUTCHMED…
Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
— HUTCHMED will host in-person presentation and online webinar on Friday, October…
